Downgrade Alert for Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded from Overweight to Equal Weight at Morgan Stanley today. The stock closed yesterday at $472.97 on volume of 870,000 shares, below average daily volume...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.